Aurélie Jonneaux

2.3k total citations · 1 hit paper
16 papers, 1.2k citations indexed

About

Aurélie Jonneaux is a scholar working on Molecular Biology, Surgery and Neurology. According to data from OpenAlex, Aurélie Jonneaux has authored 16 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Surgery and 4 papers in Neurology. Recurrent topics in Aurélie Jonneaux's work include Nerve injury and regeneration (3 papers), Ferroptosis and cancer prognosis (3 papers) and DNA Repair Mechanisms (2 papers). Aurélie Jonneaux is often cited by papers focused on Nerve injury and regeneration (3 papers), Ferroptosis and cancer prognosis (3 papers) and DNA Repair Mechanisms (2 papers). Aurélie Jonneaux collaborates with scholars based in France, United Kingdom and Australia. Aurélie Jonneaux's co-authors include David Devos, Jean-Christophe Devedjian, Kelly Timmerman, Flore Gouel, Charlotte Laloux, Régis Bordet, Caroline Moreau, Maud Pétrault, Patrick Gelé and M. Bastide and has published in prestigious journals such as Angewandte Chemie International Edition, PLoS ONE and Biomaterials.

In The Last Decade

Aurélie Jonneaux

16 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ferroptosis, a newly characterized form of cell death in Parkinson's disease that is regulated by PKC

2016 552 citations Flore Gouel, Aurélie Jonneaux et al. Neurobiology of Disease profile →

Peers

Countries citing papers authored by Aurélie Jonneaux

Since Specialization

Citations

This map shows the geographic impact of Aurélie Jonneaux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aurélie Jonneaux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aurélie Jonneaux more than expected).

Fields of papers citing papers by Aurélie Jonneaux

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aurélie Jonneaux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aurélie Jonneaux. The network helps show where Aurélie Jonneaux may publish in the future.

Co-authorship network of co-authors of Aurélie Jonneaux

This figure shows the co-authorship network connecting the top 25 collaborators of Aurélie Jonneaux. A scholar is included among the top collaborators of Aurélie Jonneaux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aurélie Jonneaux. Aurélie Jonneaux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	LIBX‐A401: A Novel Selective Inhibitor of Acyl‐CoA Synthetase Long Chain Family Member 4 (ACSL4) and Its Binding Mode 2025 ·Angewandte Chemie International Edition ·(unknown), Séverine Ravez, Didier Vertommen, Nicolas Renault, Nicolas Papadopoulos, (unknown), (unknown), Karine Porte, (unknown), Nathalie Hennuyer, Gaëtan Herinckx, (unknown), Aurélie Jonneaux, Jean‐Christophe Devedjian, David Devos, Bart Staels, Patricia Melnyk, Stefan N. Constantinescu, Raphaël Frédérick, Jamal El Bakali	4
2	LIBX‐A401: A Novel Selective Inhibitor of Acyl‐CoA Synthetase Long Chain Family Member 4 (ACSL4) and Its Binding Mode 2025 ·Angewandte Chemie ·(unknown), Séverine Ravez, Didier Vertommen, Nicolas Renault, Nicolas Papadopoulos, (unknown), (unknown), Karine Porte, (unknown), Nathalie Hennuyer, Gaëtan Herinckx, (unknown), Aurélie Jonneaux, Jean‐Christophe Devedjian, David Devos, Bart Staels, Patricia Melnyk, Stefan N. Constantinescu, Raphaël Frédérick, Jamal El Bakali	2
3	Discovery of Potent Acyl-CoA Synthetase Long-Chain Family Member 4 (ACSL4) Inhibitors with Antiferroptotic Properties 2025 ·Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), (unknown), Nicolas Renault, Aurélie Jonneaux, (unknown), (unknown), Jean‐Christophe Devedjian, Patricia Melnyk, Saı̈d Yous, David Devos, Raphaël Frédérick, Séverine Ravez, Jamal El Bakali	1
4	Alpha synuclein determines ferroptosis sensitivity in dopaminergic neurons via modulation of ether-phospholipid membrane composition 2022 ·Cell Reports ·Laura Mahoney‐Sanchez, (unknown), Ibrahim Boussaad, Aurélie Jonneaux, Kelly Timmerman, Olivier Berdeaux, Scott Ayton, Rejko Krüger, James A. Duce, David Devos, Jean-Christophe Devedjian	65
5	Alpha Synuclein Determines Ferroptosis Sensitivity in Dopaminergic Neurons via Modulation of Ether-Phospholipid Membrane Composition 2022 ·SSRN Electronic Journal ·Laura Mahoney‐Sanchez, (unknown), Ibrahim Boussaad, Aurélie Jonneaux, Kelly Timmerman, Olivier Berdeaux, Scott Ayton, Rejko Krüger, James A. Duce, David Devos, Jean-Christophe Devedjian	5
6	Whole and fractionated human platelet lysate biomaterials-based biotherapy induces strong neuroprotection in experimental models of amyotrophic lateral sclerosis 2021 ·Biomaterials ·Flore Gouel, Kelly Timmerman, (unknown), Cédric Raoul, Mary Dutheil, Aurélie Jonneaux, Guillaume Garçon, Caroline Moreau, Véronique Danel-Brunaud, James A. Duce, Thierry Burnouf, Jean-Christophe Devedjian, David Devos	18
7	Beneficial effects of atorvastatin on sex‐specific cognitive impairment induced by a cerebral microhaemorrhage in mice 2021 ·British Journal of Pharmacology ·(unknown), (unknown), (unknown), F. Auger, Antonino Bongiovanni, Meryem Tardivel, Aurélie Jonneaux, Charlotte Laloux, Camille Potey, Régis Bordet, Yaohua Chen, Sophie Gautier	2
8	The neuroprotective activity of heat-treated human platelet lysate biomaterials manufactured from outdated pathogen-reduced (amotosalen/UVA) platelet concentrates 2019 ·Journal of Biomedical Science ·Ouada Nebie, David Devos, Valérie Vingtdeux, Lassina Barro, Jean‐Christophe Devedjian, Aurélie Jonneaux, Ming‐Li Chou, Régis Bordet, Luc Buée, Folke Knutson, David Blum, Thierry Burnouf	30
9	Continuous cerebroventricular administration of dopamine: A new treatment for severe dyskinesia in Parkinson's disease? 2017 ·Neurobiology of Disease ·Charlotte Laloux, Flore Gouel, Cédrick Lachaud, Kelly Timmerman, (unknown), Aurélie Jonneaux, Maud Pétrault, Guillaume Garçon, Nathalie Rouaix, Caroline Moreau, Régis Bordet, James A. Duce, Jean-Christophe Devedjian, David Devos	17
10	Tailor-made purified human platelet lysate concentrated in neurotrophins for treatment of Parkinson's disease 2017 ·Biomaterials ·Ming‐Li Chou, (unknown), Flore Gouel, Aurélie Jonneaux, Kelly Timmerman, (unknown), Charlotte Laloux, Hung‐Ming Chang, Liang Lin, Jean-Christophe Devedjian, David Devos, Thierry Burnouf	51
11	Ferroptosis, a newly characterized form of cell death in Parkinson's disease that is regulated by PKC breakdown → 2016 ·Neurobiology of Disease ·(unknown), Flore Gouel, Aurélie Jonneaux, Kelly Timmerman, Patrick Gelé, Maud Pétrault, M. Bastide, Charlotte Laloux, Caroline Moreau, Régis Bordet, David Devos, Jean-Christophe Devedjian	552
12	Mitochondrial oxidative stress is the achille's heel of melanoma cells resistant to Braf-mutant inhibitor 2013 ·Oncotarget ·Paola Corazao-Rozas, P. Guerreschi, Manel Jendoubi, (unknown), Aurélie Jonneaux, C. Scalbert, Guillaume Garçon, Myriam Malet‐Martino, Stéphane Balayssac, Stéphane Rocchi, Ariel Savina, Pierre Formstecher, Laurent Mortier, Jérôme Kluza, Philippe Marchetti	138
13	Inactivation of the HIF-1α/PDK3 Signaling Axis Drives Melanoma toward Mitochondrial Oxidative Metabolism and Potentiates the Therapeutic Activity of Pro-Oxidants 2012 ·Cancer Research ·Jérôme Kluza, Paola Corazao-Rozas, Yasmine Touil, Manel Jendoubi, Cyril Maire, P. Guerreschi, Aurélie Jonneaux, Caroline Ballot, Stéphane Balayssac, Samuel Valable, Aurélien Corroyer‐Dulmont, Myriam Bernaudin, Myriam Malet‐Martino, Elisabeth Martin de Lassalle, Patrice Maboudou, Pierre Formstecher, Renata Polakowska, Laurent Mortier, Philippe Marchetti	121
14	Mitochondrial Electron Transport Is the Cellular Target of the Oncology Drug Elesclomol 2012 ·PLoS ONE ·Ronald K. Blackman, Kahlin Cheung-Ong, Marinella Gebbia, David A. Proia, Suqin He, Jane Kepros, Aurélie Jonneaux, Philippe Marchetti, Jérôme Kluza, Patricia E. Rao, Yumiko Wada, Guri Giaever, Corey Nislow	101
15	Exploiting Mitochondrial Dysfunction for Effective Elimination of Imatinib-Resistant Leukemic Cells 2011 ·PLoS ONE ·Jérôme Kluza, Manel Jendoubi, Caroline Ballot, (unknown), Aurélie Jonneaux, Thierry Idziorek, (unknown), (unknown), Myriam Malet‐Martino, Stéphane Balayssac, Patrice Maboudou, Gilbert Briand, Pierre Formstecher, Bruno Quesnel, Philippe Marchetti	47
16	Regulation by survivin of cancer cell death induced by F14512, a polyamine-containing inhibitor of DNA topoisomerase II 2011 ·APOPTOSIS ·Caroline Ballot, Manel Jendoubi, Jérôme Kluza, Aurélie Jonneaux, William Laine, Pierre Formstecher, Christian Bailly, Philippe Marchetti	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact